Lucid Diagnostics(LUCD) - 2024 Q4 - Earnings Call Presentation

Nasdaq: LUCD Q4 2024 Business Update Lishan Aklog, M.D. Chairman & CEO Highlights ▪ Commercial Execution Record quarterly test volume 4 – 4Q24 Revenue $1.2M – 4Q24 EsoGuard test volume 4,042: +45% Quarterly March 24, 2025 Lishan Aklog MD Dennis McGrath Chairman & CEO CFO Disclaimer 2 ▪ This presentation may contain certain forward-looking statements related to or Lucid Diagnostics Inc. (the "Company") that involve risks and uncertainties. ▪ Actual results and events may differ significantly from results and ...